Press Releases :: Cellectar Biosciences, Inc. (CLRB)

Year

Release Type

Jan 7, 2019

Cellectar Provides Update on Phase 1 Trial of CLR 131 in Relapsed/Refractory Multiple Myeloma

Jan 3, 2019

Cellectar Biosciences to Present at the Biotech Showcase

Dec 11, 2018

Cellectar Granted Japanese Patent for CLR 131

Dec 4, 2018

Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in Relapsed/Refractory Multiple Myeloma